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Multiple factors are involved in acne pathogenesis, and sebum secretion is one of the main ones. The role sebum plays in acne
development has not been completely elucidated yet; however, increasing amounts of data seem to conﬁrm the presence of
alterations in sebum from acne patients. Altered ratio between saturated and unsaturated fatty acids has been indicated as an
important feature to be considered in addition to the altered amount of speciﬁc fatty acids such as linoleic acid. Furthermore,
particular attention has been focused on squalene peroxide that seems to be able to induce an inﬂammatory response beyond
cytotoxicity and comedones formation. Moreover, recent data suggest that lipid mediators are able to interfere with sebocytes
diﬀerentiation and sebogenesis through the activation of pathways related to peroxisome proliferators-activated receptors.
Understanding the factors and mechanisms that regulate sebum production is needed in order to identify novel therapeutic
strategies for acne treatment.
1.Introduction
Acne is a skin disorder with multifactorial pathogenesis. The
mechanisms underlying its onset and subsequent develop-
ment are not yet completely clariﬁed. Among the factors
implicated in acne occurrence, sebum secretion can be
considered as the major one. Increased sebum secretion is
a characteristic of acne patients even if seborrhea per se
is not a suﬃcient condition for the development of the
pathology. Even if it is generally accepted that a correlation
exists between facial sebum outﬂow and acne severity [1–
4], it has been suggested more recently that seborrhoea does
not strictly correlate with the development of the lesions
but it aﬀects their inﬂammatory changes [5]. Along with
the increased sebum secretion, several qualitative modiﬁca-
tions have been described in acne patients, underlying the
pivotal role played by lipid mediators derived from sebum
alterations in acne pathogenesis.
2.Sebum
Human sebum is the holocrine secretion formed by the
complete disintegration of glandular cells into the follicular
duct of the pilosebaceous unit. Sebocytes are specialized cells
that synthesise lipids and accumulate them in cytoplasmic
lipiddroplets.Duringtheﬁnalstagesofdiﬀerentiation,when
they become fully mature, sebocytes undergo disintegration
and release their content, an oily and waxy material, into
the follicle [6–9]. Human sebum contains triglycerides, wax
esters, squalene, cholesterol esters, cholesterol, and free fatty
acids. Triglycerides and fatty acids, taken together, account
for the predominant proportion (57,5%), followed by wax
esters (26%) and squalene (12%). The least abundant lipid
in sebum is cholesterol, which with its esters, accounts for
the remaining 4,5% of total lipids (Table 1 and Figure 1)
[10]. Due to the complex composition, diﬀerent hypotheses
have been formulated to explain the ultimate function
of sebum. Sebaceous lipids contribute to the integrity of
the skin barrier supplying the stratum corneum with the
hydration [11, 12], providing photo-protection, particularly
against UVB [13] and delivering lipophilic antioxidants to
the skin surface [14]. Moreover, sebaceous gland lipids have
been demonstrated to have pro- and anti-inﬂammatory
properties [15, 16], and some speciﬁc lipids, such as oleic
and palmitoleic acid, have been hypothesized to exert an
antibacterial eﬀect [17]. However, the exact role of human
sebum as well as the metabolic pathways regulating its
composition and secretion has not been clariﬁed so far.2 Mediators of Inﬂammation
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Figure 1: Thin Layer Chromatography of forehead sebum. Triglyc-
erides(TG);Freefattyacids(FFA);Waxesters(WE);Squalene(SQ);
Cholesterol esters (CE); Cholesterol (CH).
Altogether, the roles played by sebum modiﬁcations and
alterations in the onset and development of acne remain to
be elucidated.
3. Sebum AlterationsandAcne
Quantitative and qualitative variations have been detected in
sebum from acne patients. The production of sebum is an
indispensable condition for the occurrence of acne, however,
sebum hypersecretion per se is not suﬃcient to trigger the
disease. Experimental and clinical data seem to address some
compositional modiﬁcation of sebum as causative factors of
clinical signs of acne.
3.1.FattyAcids:LinoleicAcid. Intheearlystudiesconcerning
acne, decreased amounts of linoleic acid in the skin surface
lipids were observed in aﬀected patients. In particular, levels
of this essential fatty acid were found signiﬁcantly lower in
wax esters making it reasonable to assume that linoleic acid
is directly involved in the sebaceous lipid synthesis [18].
Wax esters and squalene, in fact, are sebum-speciﬁc lipids.
The uptake of circulating lipids and the β-oxidation activity
are important steps for the production of the sebaceous
ones. Presumably, fatty acids are selectively utilized by the
sebaceous gland, and linoleic acid seems to be the only one
subjected to β-oxidation. It is preferentially transformed into
two carbon unit precursors leading to the generation of
acetyl-CoA that are incorporated into diﬀerent metabolic
route such as the biosynthetic pathway leading to squalene
and wax esters synthesis. In experimental models, linoleic
acid β-oxidation seems to correlate with speciﬁc sebaceous
lipid production (wax esters) and thus with sebocytes
functions and diﬀerentiation [19].
A diminished amount of linoleic acid in the sebum has
been suggested to aﬀect the composition of sphingolipids
Table 1: Components of skin surface lipids. Triglycerides (TG); Free
fatty acids (FFA); Wax esters (WE); Squalene (SQ); Cholesterol
Esters (CE); Cholesterol (CH).
Sebum (%) Epidermal lipids (%)
TG 30–50 30–35
FFA 15–30 8–16
WE 26–30 —
SQ 12–20 —
CE 3.0–6.0 15–20
CH 1.5–2.5 20–25
in the follicle. Acne patients show a lower percentage of
acyl-ceramides containing linoleic acid. Depletion of linoleic
acid in sphingolipids has been hypothesized to be involved in
thefollicularhyperkeratosis,whichisacrucialeventinvolved
in the comedones formation [20]. Moreover, low levels of
linoleic acid also lead to impairment of the epidermal barrier
function and predispose to the increased permeability of
comedonal wall to inﬂammatory substances [21].
3.2. Fatty Acids: Saturated and Unsaturated Pattern. Recent
studies have reported a signiﬁcantly diﬀerent ratio between
saturated and unsaturated fatty acids in acne. In particular,
the C16:0/C16:1 ratio in the skin surface triglycerides and
waxestersishigherinacne[22,23].Increasedsebumoutﬂow
and severity of clinical manifestations were associated with
an alteration in the proportion of monounsaturated fatty
acids suggesting that desaturation of fatty acids may play a
majorroleinsebogenesisandacneonset.Thedesaturasethat
yields unsaturated fatty acids of the type found in sebum
inserts a double bond at the position Δ6 of the carbon
backbone. This enzyme, known either as Δ6 desaturase or
fatty acid desaturase-2 (FADS-2), is detectable mainly in
diﬀerentiated sebocytes, which occupy the suprabasal layers
of the sebaceous gland and have reached a full lipid synthetic
capacity. Δ6 desaturase can be considered as a functional
marker of activity and diﬀerentiation of sebocytes [24], and
leads to the formation of fatty acids with a peculiar pattern
of unsaturation. In particular, Δ6 desaturase acts on palmitic
acid (C16:0) to produce sapienic acid (C16:1Δ6), the most
abundant fatty acid in human sebum. This unusual fatty
acid with a desaturation at the Δ6 position instead of the
Δ9 position has not been identiﬁed in any other human
tissue nor in sebum secretion of other animals. A fatty
acid unique to sebum, such as sebaleic acid (C18:2Δ5,8),
presents a sebaceous pattern of unsaturations consequent
to the elongation by two carbons of the precursor sapienic
acid and the additional insertion of a double bond (Figure 2)
[24]. The ratio between Δ6a n dΔ9 unsaturated fatty acids
has been proposed as an index of maturation of sebaceous
cells and of metabolic process associated to it [25]. Incorrect
activity of speciﬁc desaturase enzymes and/or excessive
sebum secretion can result in an alteration of the relative
proportion of the diﬀerent fatty acids, and consequently in
the within-class distribution of lipids constituting sebum,
leadingtocompositionalchangesthatcandrivetowardsacne
development.Mediators of Inﬂammation 3
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Figure 2: Characteristic components of sebaceous secretion. Squalene is a lipid exclusive of human sebaceous secretion. Among fatty acids,
there are some with a peculiar pattern of unsaturation (sapienic and sebaleic acid) and some with a particular chemical structure (branched
fatty acids).
3.3. Squalene and Squalene Peroxide. The modiﬁcations of
lipid composition illustrated so far in the acne sebum are
the result of an incorrect lipid synthesis in the sebaceous
gland. Post synthetic compositional changes can occur due
to diﬀerent factors, which remain to be clariﬁed. Among
the lipids proposed as having a role in the development of
comedones, particular attention has been focused on lipid
peroxidation products. A recent study has demonstrated that
the accumulation of lipid peroxides may be responsible for
the inﬂammatory changes in comedones. In particular, it has
been observed that the degree of lipoperoxidation as well
as interleukin-1-alpha and NF-kappaB content are higher
in inﬂammatory lesions than that in noninﬂammatory
ones [26]. These data further support previous ﬁndings
suggesting an association between sebum oxidation and acne
progression, strengthening the role of lipid peroxidation in
acne pathogenesis. Squalene peroxidation products continue
to receive particular attention considering that squalene,
together with wax esters, represents characteristic products
of sebaceous secretion. In fact, squalene and wax esters have
a particularly high concentration in sebum and are not
found among the epidermal surface lipids. Biosynthesis of
wax esters is important for the sebaceous gland survival.
DGAT are key enzymes involved in sebogenesis. The DGAT1
isoform catalyzes the sysnthesis of wax esters, unlike DGAT2
that leads to triacylglycerols [27]. Squalene is a linear inter-
mediate preceding cholesterol in its biosynthetic pathway. In
the sebaceous gland conversion of squalene to lanosterol and
then to cholesterol is negligible. The reason why squalene is
accumulated in sebocytes still awaits further investigations.
There are diﬀerent possibilities that might explain the high
squalene content in sebum. On one side, in sebocytes there
might be an increased expression and/or activity of the
enzyme that produces squalene, namely squalene synthase;
on the other one the enzymes involved in the transformation
of squalene into cholesterol, which include squalene-2,3-
epoxidase and oxidosqualene cyclase, might be repressed.
Considering that sebaceous gland possesses a peculiar
environment characterized by an anaerobic condition, and
that squalene-2,3-epoxidase needs oxygen to proceed in
its reaction, it is reasonable to speculate that squalene
accumulationinsebocytesisduetothepeculiarenvironment
ofthesebaceousgland[8].Forallabovementioned,squalene
may be considered as a marker of sebocytes diﬀerentiation
and therefore of sebogenesis [15]. Following UV exposure,
squalene undergoes massive photodegradation due to its
highly unsaturated chemical structure. Irradiation of human
skin leads to a squalene decomposition of about 60% similar
to that observed in vitro on the puriﬁed compound [28].
Oxidative challenge generates, in human skin surface lipids,
squalene monohydroperoxide as the main product [29].
Several optional isomers of squalene monohydroperoxide
have been identiﬁed. Additional peroxidation of squalene
monohydroperoxide can also occur. Altogether, squalene
peroxidation byproducts exert harmful eﬀects in vivo and
in skin cell cultures. In particular, keratinocytes cytotoxicity
[28], histological changes, and immunosuppressive eﬀects
have been observed [30]. Comedogenicity of squalene per-
oxides has been demonstrated in animal experiments in
which comedones have been induced by exposing rabbit
ears to irradiated squalene. The degree of squalene per-
oxidation was found to correlate positively with the size
of the comedones elicited. In addition, the treatment of
ear skin with squalene peroxidation by-products caused
marked hyperplasia and hyperkeratosis of the epithelium
in follicular infundibulum, and increased the proliferation
of the sebaceous glands [31]. These eﬀects were speciﬁcally
caused by squalene monohydroperoxide whereas the all4 Mediators of Inﬂammation
Table 2:Harmfuleﬀectsofsqualeneperoxidation.Theadverseeﬀects
of squalene peroxidation products and in particular of squalene
monohydroperoxide have been assessed both in vitro and in vivo.
Moreover, sebum from acne patients seems to have high level of
squalene peroxide.
Squalene peroxidation
Harmful eﬀects Acne sebum
Comedogenicity
Increased amount of squalene
peroxidation products accompanied
by decreased level of vitamin E
Sebaceous gland
hyperplasia
Hyperkeratosis
Release of inﬂammatory
mediators from
keratinocytes
saturated squalene form (squalane), squalene itself and syn-
thetic peroxides with diﬀerent backbone structures, exerted
a negligible comedogenic eﬀect and did not lead to skin
roughness and wrinkling [32, 33]. In vitro experiments
have shown that squalene peroxides, beyond induction of
keratinocytes proliferation, led also to the upregulation and
release of inﬂammatory mediators, such as interleukine-
6. Overall, these eﬀects clearly suggest a proinﬂammatory
activity of squalene oxidation products [34]. The onset of
inﬂammatory reactions appears to be an early event in the
developmentofacnelesions[35,36].Theoxidativechallenge
supplied with peroxidated squalene can be aggravated by its
potential glutathione-depleting activity which results in an
increased cytotoxicity and comedogenicity [37]. To limit the
harmful eﬀects of peroxidated squalene, the skin is equipped
with endogenous defense system. Vitamin E is a lipophilic
antioxidant supplied to the skin surface through the sebum
outﬂow. In skin areas with elevated sebaceous glands density
a continuous secretion of vitamin E is observed, which is in
tight correlation with the levels of cosecreted squalene. This
positive correlation highlights a physiological antioxidant
strategy put in place to counteract the generation of squalene
oxidation products [14]. The crucial role played by squalene
peroxidation in acne development is strengthened by the
observation that either skin surface and comedone lipids
collected from acne patients are enriched in polar lipids
mainly derived from squalene oxidation [38, 39]. Moreover,
recentdatahavefurtherconﬁrmedtheseﬁndings.Signiﬁcant
diﬀerences have been detected in the levels of squalene and
vitamin E in sebum from acne patients and healthy subjects.
In particular, a higher amount of squalene peroxide and
a decreased level of vitamin E have been detected in acne
sebum [40]. This ﬁnding further strengthens a role of lipid
peroxidationby-products,particularlysqualeneperocides,in
the onset and development of acne [41, 42]( Table 2).
4.Sebum,OxidativeStress,PPARs,
and Inﬂammation
Modiﬁcations of the sebum composition, due to lipoperox-
idation and anomalous distribution of fatty acids, impact
keratinocytes proliferation and diﬀerentiation. Importantly,
lipid peroxidation products are also capable of inducing
production of pro-inﬂammatory cytokines and activation
of peroxisome proliferators-activated receptors (PPARs).
PPARs are nuclear transcription factors involved in the
control of lipid metabolism as well as in the control of
inﬂammation.Modulationofinﬂammatorypathwaysresults
from the antagonism of the NF-κB activation and the
promotion of the pro-inﬂammatory eicosanoids catabolism
[43]. Among the diﬀerent isoforms, PPARα and PPARγ are
considered the main ones involved in the sebocytes biology.
In particular, PPARα seems to be related to β-oxidation of
fatty acids and lipid catabolism, whereas PPARγ activation
has been linked to lipidogenesis [44]. Eicosanoid metabolites
originated from the arachidonic acid cascade, namely LTB4
and 15-HETE, have been shown to be ligands of PPARα
and PPARγ,r e s p e c t i v e l y[ 45, 46]. Interestingly, the enzymes
involved in their formation, including 5-lipoxygenase (5-
LOX), have been found to be expressed at higher extent in
acne-involved skin in comparison to the skin of healthy sub-
jects. In addition, in acne-aﬀected skin, enhanced expression
ofIL-6andIL-8hasbeenalsofound[47].LOXproductshave
been implicated in inﬂammatory skin diseases characterized
by keratinocytes hyperproliferation [48, 49]. Activation of 5-
LOX results, among other eﬀects, in induced IL-6 and IL-8
expression in human sebocytes. Systemic treatment of acne
patients with a 5-LOX inhibitor reduces the inﬂammatory
lesions count and the synthesis of sebum lipids, in particular,
of those with pro-inﬂammatory potential [41, 50]. 5-LOX
inhibitors may also downregulate the inﬂammatory activity
of lymphocytes and macrophages resulting in cumulative
beneﬁcial eﬀects [51].
Prostaglandins are other pro-inﬂammatory mediators
thought to be involved in acne lesion development [52].
Mouse with increased cyclooxygenase-2 (COX-2) expression
and prostaglandins E2 (PGE2) levels showed sebaceous gland
hyperplasiaandenhancedsebumproduction[53]suggesting
an important role for COX-2 signaling pathway in sebocytes
biology. In in vitro models, it has been demonstrated that
expression and activation of COX-2 is PPARγ mediated.
General oxidative stressors, including lipid oxidizing agents,
have been shown to activate PPARγ and to induce lipo-
genesis in sebocytes [52–55]. All these ﬁndings allow to
hypothesize that sebocytes proliferation and/or lipogenesis
as well as inﬂammatory reactions may be regulated by
PPARγ-mediated pathways. Clinical data, demonstrating
upregulated expression of both COX-2 and PPARγ in acne
involved skin, support this hypothesis [47]a n da d dn e w
insights on acne pathogenesis. Taken together, all these
ﬁndingssuggestacomprehensivelinkbetweeninﬂammation
and sebogenesis supporting the deﬁnition of acne as an
inﬂammatory disease in which lipid mediators play a central
role.
5. Conclusion
Sebum production is considered one of the principal factors
involved in acne development. Great eﬀorts have been made
and are currently devoted to studying the factors that
regulate sebum composition and secretion. In particular,Mediators of Inﬂammation 5
the pathways leading to the formation of lipids typically
sebaceous, such as branched fatty acids and fatty acids with
uncommon unsaturation patterns, remain to be elucidated.
Modiﬁcations in the amount, type and, arrangement of fatty
acids constituting sebum lipids have been observed in acne
patients. By-products of lipid peroxidation, in particular
squaleneperoxide,havebeenrecognizedtoplayacrucialrole
i nt h ed e v e l o p m e n to fi n ﬂ a m m a t o r yr e a c t i o n sa sw e l la si n
cytotoxicity and comedogenesis. A number of lipid medi-
ators have been demonstrated to be PPARγ ligands aﬀect-
ing sebocytes biology, in particular their lipid metabolism
and synthesis. Moreover, PPARγ activation seems to be
necessary for COX-2 signaling pathway induction. Clinical
data indicating increased expression of COX-2 and PGE2 in
acne involved skin associated with enhanced release of pro-
inﬂammatory cytokines and a higher degree of lipoperoxida-
tion further support the interplay between lipoinﬂammation
and lipid signaling. However, the lack of deﬁnitive data
underlines the importance of acquiring detailed information
of lipid molecules speciﬁcally involved in acne pathogenesis.
Improvement of the knowledge on the function of sebum,
on the mechanism that regulate its production, and on
the role of alteration in sebum organization represents a
fundamental step for the identiﬁcation of new targets for
innovativetherapeuticstrategiesaimingtocorrectthesebum
d e r e g u l a t i o ni na c n e .
Abbreviations
Sq: Squalene
C16:0: Palmitic acid
C16:1 Δ6: Sapienic acid
C18:2 Δ5,8: Sebaleic acid.
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